- Home
- IMOS vs CGEM Comparison
IMOS vs CGEM Comparison
Compare IMOS & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMOS
- CGEM
- Stock Information
- Founded
- IMOS 1997
- CGEM 2016
- Country
- IMOS Taiwan
- CGEM United States
- Employees
- IMOS N/A
- CGEM N/A
- Industry
- IMOS Semiconductors
- CGEM Biotechnology: Pharmaceutical Preparations
- Sector
- IMOS Technology
- CGEM Health Care
- Exchange
- IMOS Nasdaq
- CGEM Nasdaq
- Market Cap
- IMOS 534.3M
- CGEM 482.7M
- IPO Year
- IMOS N/A
- CGEM 2021
- Fundamental
- Price
- IMOS $19.36
- CGEM $6.34
- Analyst Decision
- IMOS
- CGEM Strong Buy
- Analyst Count
- IMOS 0
- CGEM 8
- Target Price
- IMOS N/A
- CGEM $27.25
- AVG Volume (30 Days)
- IMOS 16.6K
- CGEM 571.2K
- Earning Date
- IMOS 11-04-2025
- CGEM 11-06-2025
- Dividend Yield
- IMOS 3.36%
- CGEM N/A
- EPS Growth
- IMOS N/A
- CGEM N/A
- EPS
- IMOS 0.01
- CGEM N/A
- Revenue
- IMOS $777,452,000.00
- CGEM N/A
- Revenue This Year
- IMOS $3.76
- CGEM N/A
- Revenue Next Year
- IMOS $5.93
- CGEM N/A
- P/E Ratio
- IMOS $115.81
- CGEM N/A
- Revenue Growth
- IMOS 0.89
- CGEM N/A
- 52 Week Low
- IMOS $12.78
- CGEM $5.89
- 52 Week High
- IMOS $23.85
- CGEM $18.62
- Technical
- Relative Strength Index (RSI)
- IMOS 71.64
- CGEM 38.68
- Support Level
- IMOS $18.30
- CGEM $5.89
- Resistance Level
- IMOS $18.66
- CGEM $6.76
- Average True Range (ATR)
- IMOS 0.36
- CGEM 0.41
- MACD
- IMOS 0.31
- CGEM -0.09
- Stochastic Oscillator
- IMOS 100.00
- CGEM 23.32
About IMOS ChipMOS TECHNOLOGIES INC.
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.